Scibase
  • HOW IT WORKS
    • INDICATION FOR USE
    • HOW IT WORKS
    • HOW TO MEASURE
    • THE EIS TECHNOLOGY
    • CLINICAL STUDIES
    • CLINICAL BENEFITS
    • RESEARCH MILESTONES
    • PUBLICATIONS
    • PATIENT LESION CARDS
  • FOR PATIENTS
    • SKIN CANCER INFORMATION
    • FIND CLINICS
    • SELF EXAMINATION
    • PATIENT ORGANIZATIONS
    • PATIENT LABELING
  • SCIBASE
    • ABOUT SCIBASE
    • AVAILABLE MARKETS
    • WE ARE SCIBASE
    • NEWS & EVENTS
    • CEO-LETTERS
    • AVAILABLE MATERIALS
    • FINANCIAL INFORMATION
    • CONTACT
  • INVESTORS
  • CONTACT US
  • The Nevisense Product
    • How it works
    • How to measure
    • The EIS Technology
    • Clinical studies
    • Clinical benefits
    • Publications
    • Patient lesion cards
  • For patients
    • Skin cancer information
    • Find clinics
    • Self examination
    • Patient organizations
    • Patient Labeling
  • About Scibase
    • About Scibase
    • Available Markets
    • We are Scibase
    • News & events
    • Available materials
    • Contact us
    • Privacy and Cookie policy
    • Login
  • Investors
    • About Scibase
    • Press releases
    • Business model
    • Corporate Governance
    • Contact

The only FDA approved point-of-care technology for detection of melanoma

Atlantic Derm Conference 2019

  • The Nevisense Product
    • How it works
    • How to measure
    • The EIS Technology
    • Clinical studies
    • Clinical benefits
    • Publications
    • Patient lesion cards
  • For patients
    • Skin cancer information
    • Find clinics
    • Self examination
    • Patient organizations
    • Patient Labeling
  • About Scibase
    • About Scibase
    • Available Markets
    • We are Scibase
    • News & events
    • Available materials
    • Contact us
    • Privacy and Cookie policy
    • Login
  • Investors
    • About Scibase
    • Press releases
    • Business model
    • Corporate Governance
    • Contact